When heart devices disappoint, portfolios can too. In this episode of Sue Wall Street, we dive into the class action lawsuit against Integer Holdings $ITGR, filed by the West Palm Beach Firefighters’ Pension Fund. Accusations fly over allegedly misleading statements about cardiac tech demand, leading to a brutal 32% stock crash. If you’re an investor, whistleblower, or just tracking medtech markets, this one’s for you. Expect sharp analysis, real talk, and no sugarcoating. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Blue Owl Capital $OWL is in the hot seat after a surprise merger move left some investors trapped and staring down a 20 percent loss. In this episode of Sue Wall Street, Cassie and Bill unravel what went down with the halted redemptions, the OBDC merger, and the class action lawsuit that followed. This one’s for investors, financial watchdogs, and anyone tracking the private credit boom. Expect deep dives, sharp banter, and no fluff just facts. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

StubHub $STUB went public with fanfare then revealed a 143% plunge in free cash flow just weeks later. In this episode of Sue Wall Street, Cassie and Bill break down the class action lawsuit alleging StubHub’s IPO disclosures misled investors by hiding critical financial trends. With big-name underwriters and a 56% stock drop, this one's a must-listen for IPO watchers and retail investors. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Sprouts Farmers Market $SFM hyped consumer “tailwinds” and raised guidance in July then slashed forecasts three months later, triggering a 26% stock plunge in one day. In this episode of Sue Wall Street, Cassie and Bill dig into the class action lawsuit alleging misleading optimism, ignored internal data, and inflated growth projections. Perfect for retail investors, ESG followers, and anyone tracking grocery sector drama. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Jayud Global Logistics $JYD soared from $1 to nearly $8—then collapsed 95% overnight. In this episode of Sue Wall Street, we dive into the class action lawsuit alleging a coordinated pump-and-dump scheme, misleading financials, and silence from auditors. With fake stock tips, insider control, and offshore structures, investors say this was built to blow. Perfect for retail traders, audit watchdogs, and market skeptics. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

DeFi Technologies $DEFT promised a low-risk, high-reward crypto arbitrage strategy through its DeFi Alpha desk claiming steady returns and booming growth. But after raising $100M from investors, they quietly admitted those trades weren’t happening. In this episode of Sue Wall Street, Cassie and Bill break down the lawsuit alleging securities fraud, inflated projections, and a CEO exit. For crypto investors, fintech skeptics, and anyone watching the digital asset space. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Bitdeer Technologies $BTDR hyped its revolutionary SEALMINER A4 chip as a game-changer in Bitcoin mining claiming cutting-edge efficiency and breakthrough innovation. But when the real numbers dropped, the chip underperformed, delays piled up, and the stock plunged over 14% in a day. In this episode of Sue Wall Street, we unpack the lawsuit accusing Bitdeer of misleading investors and inflating expectations. For crypto traders, tech investors, and market skeptics. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Alexandria Real Estate $ARE touted its Long Island City property as a cornerstone of life sciences growth—until a shocking $323.9M impairment revealed the cracks. In this episode of Sue Wall Street, Cassie and Bill unpack the securities fraud allegations, the alleged “megacampus” misrepresentations, and why investors say they were misled. Perfect for real estate investors, REIT-watchers, and anyone tracking Wall Street transparency. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Skye Bioscience $SKYE promised a breakthrough obesity drug—but when human trial results dropped, it didn’t even outperform a placebo. The stock plunged 60% in one day, and now executives are accused of cashing out while pumping up investor expectations. This episode of Sue Wall Street breaks down the lawsuit, the science spin, and what it means for biotech investors, traders, and anyone chasing the next pharma moonshot. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Perrigo $PRGO plunged 25 percent in one day after announcing a full review of its infant formula business—just two years after acquiring it. In this episode of Sue Wall Street, Cassie and Bill unpack how $240M in planned investments, rosy projections, and mounting losses turned into allegations of securities fraud. If you’re an investor, legal buff, or love corporate drama, this one's for you. Expect sharp takes, deep dives, and straight talk on shareholder rights. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Telix Pharmaceuticals $TLX is facing a federal subpoena and a scorching class action lawsuit after allegedly misleading investors about its prostate cancer drug pipeline and FDA compliance. In this episode of Sue Wall Street, we dive into how missing trial data, shady supply chain claims, and a bombshell FDA rejection sent the stock tumbling. Ideal for biotech investors, legal watchers, and anyone tracking pharmaceutical accountability. Get the facts, not just the filings. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Primo Brands $PRMB told investors their mega-merger was going “flawlessly” but behind the scenes, tech failures, service chaos, and internal breakdowns were flooding the company. In this episode of Sue Wall Street, we unpack how confident corporate spin turned into a shareholder disaster and triggered a class action lawsuit after a stunning 36% stock drop. If you follow M&A hype, beverage brands, or securities fraud cases, this one’s for you. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Online learning giant Stride Inc $LRN is under fire for allegedly inflating enrollment with “ghost students” to boost funding triggering a massive stock crash and a class action lawsuit. In this episode of Sue Wall Street, we dive into whistleblower claims, fake student rosters, overworked teachers, and missed special ed services. Perfect for investors, educators, and anyone tracking EdTech accountability. Expect shocking details, legal breakdowns, and stock fallout. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Firefly Aerospace $FLY promised liftoff but shareholders got a crash landing. In this episode of Sue Wall Street, we break down how failed rocket launches, FAA groundings, and misleading IPO statements led to a fiery class action lawsuit. If you're into space stocks, IPO hype, or financial accountability, this is your orbit. Expect sharp analysis, timeline breakdowns, and insider commentary. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

A deadly mud rush at Freeport-McMoRan’s $FCX Grasberg mine in Indonesia has triggered more than tragedy it’s now the center of a major class action lawsuit. In this gripping episode of Sue Wall Street, we break down how safety failures, misleading disclosures, and a steep stock plunge are fueling investor outrage. If you're into mining stocks, ESG accountability, or securities law drama, this one’s for you. Expect expert analysis, real talk, and financial firepower. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Molina Healthcare $MOH stunned investors by slashing earnings forecasts—twice—in just two weeks, triggering a stock freefall and a major class action lawsuit. This episode of Sue Wall Street dives into how inflated guidance, hidden medical cost spikes, and shocking disclosures led to shareholder chaos. Perfect for investors, finance nerds, and corporate accountability watchdogs. Expect sharp commentary, deep dives, and eye-popping numbers. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

In this episode, we break down the class action lawsuit against Avantor $AVTR after the life sciences giant allegedly misled investors while bleeding accounts, slashing guidance, and posting a massive $785M goodwill impairment. From rosy earnings calls to brutal stock drops, we reveal how investor trust evaporated. Perfect for biotech watchers, institutional investors, and Wall Street skeptics. Get legal insights, sharp commentary, and real accountability. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

This episode exposes the class action lawsuit against DexCom $DXCM after unauthorized changes to its G6 and G7 glucose sensors sparked FDA warnings, tragic outcomes, and a brutal stock plunge. We break down how misleading safety claims and insider stock sales may have violated securities laws. Ideal for medtech investors, financial sleuths, and patient advocates. Expect sharp takes, real cases, and deep accountability. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

We uncover the class action lawsuit against Inspire Medical Systems $INSP after their highly touted Inspire V rollout turned out to be a total sleepwalking disaster. From training failures to billing chaos and low demand, the company painted a glowing picture while reality burned. Perfect for investors, analysts, and anyone tracking medtech risks. Expect sharp breakdowns, legal insight, and cautionary tales. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

In this episode, we dig into the class action lawsuit against CarMax $KMX after a 20 percent stock nosedive. Did execs hype their financials during a short-lived buying boom fueled by tariff rumors? Investors say yes and the legal fallout could shake up how companies spin short-term wins. Ideal for retail traders, shareholders, and finance buffs. Expect sharp banter, legal insights, and Wall Street accountability. Visit ZLK.com for more info. Add our WhatsApp Channel. We’re not lawyers or accountants, so don’t take this as legal or financial advice.